Voyageur Pharmaceuticals (CVE:VM) Shares Up 17.6% – Still a Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM) were up 17.6% on Monday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 134,500 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 256,409 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Performance

The company has a quick ratio of 0.84, a current ratio of 0.10 and a debt-to-equity ratio of 4.23. The stock has a market capitalization of C$27.27 million, a P/E ratio of -16.84 and a beta of 0.32. The business has a fifty day moving average price of C$0.16 and a 200-day moving average price of C$0.10.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.